Company Performance Compass Pathways has shown resilience in its financial performance by aligning its EPS with market expectations. The company reported a net loss of 155.1 million dollars for 2024, ...

Compass Pathways’ stock performance in the upcoming months is likely to be closely tied to the Phase 3 trial results for ’360. With the reaffirmed Buy rating and $23.00 price target, TD Cowen signals ...

View COMPASS Pathways Plc Sponsored ADR CMPS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Recent attention on COMPASS Pathways (CMPS) centers on its first quarter 2026 ...

Compass Pathways Plc (NASDAQ: CMPS) stock has reached a new 52-week low, touching down at $3.85. This latest price point marks a significant downturn for the company, which specializes in mental ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards ...

Compass Pathways Plc (NASDAQ: CMPS) stock has reached a new 52-week low, touching down at $3.99, with a market capitalization of $276 million. This latest price point marks a significant drop for the ...

Is CMPS a good stock to buy? We came across a bullish thesis on COMPASS Pathways plc on BioEquity Watch’s Substack. In this ...

FDA granted Compass NDA rolling submission and review request, based on strength of Phase 3 data CNPV awarded for COMP360 in TRD, further accelerating momentum 26-week (Part B) data from COMP006, ...

Participants received a single dose of either 25 mg of COMP360 or placebo On track for disclosure of top-line 6-week primary endpoint results in late June LONDON & NEW YORK--(BUSINESS WIRE)--Compass ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...